many synthetic operations as long as the E synthon (1a) was
used. We therefore judge that the stereoisomeric purity of
1a that is readily preparable from 3-butyn-1-ol in two steps3,4
in 77% overall yield must be infinitesimally close to 100%
(Scheme 1). The Z isomer of 1a, i.e., 1b, has recently become
now be achieved for efficient, clean, and iterative construc-
tion of oligoisoprenoids. Although we have previously
reported the treatment of homoallyl and homopropargyl
halides containing Br or I with Mg in the presence of zinc
halides as a satisfactory procedure,6 it is less clean, producing
some dimeric and other byproducts, and less dependable in
highly demanding cases, such as those discussed herein. The
difference is further accentuated in iterative synthetic opera-
tions without isolation of intermediates.
Scheme 1
Fourth, the use of 1 requires terminations at both ends of
an isoprenoid chain termed “head capping” and “tail
modification” for the sake of convenience. Head capping
merely requires the Pd-catalyzed homoallyl-alkenyl coupling
discussed above with an appropriate 2-methyl-1-alkenyl
iodide, while modification of terminal alkynes at the tail to
produce (E)- and (Z)-3-methyl-2-alken-1-ols is most conve-
niently achieved by using our one-pot Zr-catalyzed methyl-
alumination-ate complexation-hydroxymethylation11 and
Sato’s two-step alkyne hydroxymethylation-Ti-catalyzed
syn-hydromagnesation-methylation,12 respectively.
The potential synthetic utility of the protocol incorporating
those features discussed above is indicated by an efficient
and selective iterative and convergent synthesis of coenzyme
Q10 (2)13 from 1a, 4-iodo-1-trimethylsilyl-1-butyne (3), (E)-
1-iodo-2,6-dimethyl-1,5-heptadiene (4), and 2,3-dimethoxy-
4-chloromethyl-5-methyl-1,4-benzoquinone (5)14 in nine
steps in 26% overall yield (Scheme 2). No stereoisomeric
separation was attempted in the synthesis of 98% (all-E)-2.
It should also be noted that all nine stereodefined C5 isoprene
units were linked and incorporated into coenzyme Q10 (2)
only in nine synthetic operations.
The reaction of alkenylalanes with allyl or benzyl chlorides
can be achieved by using either Ni or Pd catalysts, as we
originally reported in 1981,15 but the Ni-catalyzed reaction
revealed a minor tendency to undergo double bond isomer-
ization of the cross-coupled products in some cases. A more
recent report14 claimed the superiority of Ni catalysts over
Pd catalysts in terms of reaction rate and product yield, and
we in fact completed our synthesis of coenzyme Q10 using
a Ni catalyst, which proved to be highly satisfactory. Further
experiments summarized in Scheme 3, however, suggest that
Pd catalysts are also very satisfactory in cases where
chloromethylquinones are used as the electrophilic cross
coupling partner.
accessible via thermal rearrangement of the product obtained
by Zr-catalyzed carboalumination of 3-butyn-1-ol,5 although
the long reaction time for thermal isomerization and the 98%
isomeric purity level leave some room for improvement
(Scheme 1).
Second, the Pd-catalyzed homoallyl-alkenyl and homopro-
pargyl-alkenyl cross coupling of 1 with homoallylzinc and
homopropargylzinc6 derivatives developed by us can proceed
selectively and in high yields without a sign of any
isomerization through the use of Cl2Pd(dppf)7 as a catalyst.
3
Particularly noteworthy is that the Csp -bound homoallylic
or homopropargylic I or Br does not compete to detectable
3
2
extents with the Csp -bound I or Br, as reported first by us,
permitting clean and selective elongation with 1a or 1b in
the T-to-H direction.
Third, lithiation of primary alkyl iodides via Li-I ex-
change reported by us8 and Bailey9 in 1990 leads to the
formation of the corresponding alkyllithiums generally in
almost quantitative yields with little or no sign of any side
reactions even in those cases where the alkyl groups are
homoallyl, homopropargyl, and homobenzyl.10 Coupled with
another essentially quantitative Li-to-Zn transmetalation, an
exceedingly clean and highly dependable generation of the
requisite homoallyl- and homopropargylzinc derivatives can
(11) Okukado, N.; Negishi, E. Tetrahedron Lett. 1978, 2357.
(12) Sato, F.; Ishikawa, H.; Watanabe, H.; Miyake, T.; Sato, M. J. Chem.
Soc., Chem. Commun. 1981, 718.
(3) Rand, C. L.; Van Horn, D. E.; Moore, M. W.; Negishi, E. J. Org.
Chem. 1981, 46, 4093.
(4) For seminal papers on the Zr-catalyzed carboalumination, see (a) Van
Horn, D. E.; Negishi, E. J. Am. Chem. Soc. 1978, 100, 2252. (b) Negishi,
E.; Van Horn, D. E.; Yoshida, T. J. Am Chem. Soc. 1985, 107, 6639. (c)
Negishi, E. Pure Appl. Chem. 1981, 53, 2333.
(5) Ma, S.; Negishi, E. J. Org. Chem. 1997, 62, 784.
(6) (a) Negishi, E.; Valente, L. F.; Kobayashi, M. J. Am. Chem. Soc.
1980, 102, 3298. (b) Kobayashi, M.; Negishi, E. J. Org. Chem. 1980, 45,
5223.
(7) Hayashi, T.; Konishi, K.; Kumada, M. Tetrahedron Lett. 1979, 1871.
(8) Negishi, E.; Swanson, D. R.; Rousset, C. J. J. Org. Chem. 1990, 55,
5406.
(13) (a) Littaru, G. P.; Ho, L.; Folkers, K. Int. J. Vitam. Nutr. Res. 1972,
42, 291. (b) Blizmakov, E. G.; Hunt, G. L. The Miracle Nutrient Coenzyme
Q10, Bantom Books, New York, 1987. For representative approaches to
the synthesis of these targets, see (c) Eren, D.; Keinan, E. J. Am. Chem.
Soc. 1988, 110, 4356. (d) Ru¨ttimann, A.; Lorenz, P. HelV. Chim. Acta 1990,
73, 790. (e) Yanagisawa, A.; Nomura, N.; Noritake, Y.; Yamamoto, H.
Synthesis 1991, 1130. (f) Lipshultz, B. H.; Bulow, G.; Fernandez-Lazaro,
F.; Kim, S.-K.; Lowe, R.; Mollard, P.; Stevens, K. L. J. Am. Chem. Soc.
1999, 121, 11664 and references therein.
(14) (a) Lipshutz, B. H.; Bulow, G.; Lowe, R.; Stevens, K. L. Tetrahedron
1996, 52, 7265. (b) Lipshutz, B. H.; Kim, S.-K.; Mollard, P.; Stevens, K.
L. Tetrahedron 1998, 54, 1241.
(15) (a) Matsushita, H.; Negishi, E. J. Am. Chem. Soc. 1981, 103, 2882.
(b) Negishi, E.; Matsushita, H.; Okukado, N. Tetrahedron Lett. 1981, 22,
2715. (c) Negishi, E.; Chatterjee, S.; Matsushita, H. Tetrahedron Lett. 1981,
22, 3737.
(9) Bailey, W. F.; Punzalan, E. R. J. Org. Chem. 1990, 55, 5404.
(10) The use of alkyl bromides and secondary alkyl iodides leads to
complex and/or unsatisfactory products.
262
Org. Lett., Vol. 4, No. 2, 2002